Aggressive treatment often needed for hypotony maculopathy
October 1st 2004New York-Hypotony maculopathy-damage to the macula caused by clinically significant low IOP-has several causes, including overfiltering blebs, bleb leak, cyclodialysis cleft, and ciliary body effusion/detachment, reported Celso Tello, MD, at the Glaucoma 2004 meeting here.
New Orleans hosts first joint meeting of AAO, SOE
October 1st 2004That particular charm that belongs only to New Orleans has lured the American Academy of Ophthalmology (AAO) back to this magical city for its annual meeting.The 2004 meeting is the first joint meeting with the European Society of Ophthalmology (SOE).The main meeting will be preceded by 2 days of subspecialty presentations on Friday, Oct. 22 and Saturday, Oct. 23. All subspecialty day events and those of the main conference, Oct. 23 to 26, will be held at the Ernest N. Morial Convention Center.
Lasker Award lauds Dr. Kelman for medical innovation
October 1st 2004New York-The 2004 Albert Lasker Award for Clinical Medical Research, given posthumously, honors Charles D. Kelman, MD, for transforming cataract surgery "from a risky and lengthy ordeal (2-week hospital stay) into a safe and quick outpatient procedure that has spared millions of people throughout the world from blindness," as well as for inspiring similar advances in a number of other medical specialties.
Lasker Award lauds Dr. Kelman for medical innovation
October 1st 2004New York-The 2004 Albert Lasker Award for Clinical Medical Research, given posthumously, honors Charles D. Kelman, MD, for transforming cataract surgery "from a risky and lengthy ordeal (2-week hospital stay) into a safe and quick outpatient procedure that has spared millions of people throughout the world from blindness," as well as for inspiring similar advances in a number of other medical specialties.
Ophthalmic community celebrates Dr. Kelman's life
October 1st 2004New York-It is not usual for a memorial ceremony to be punctuated by roars of laughter, but the commemoration held here on Sept. 13 for Charles D. Kelman, MD, was as unusual as the man himself. The tribute was as full of the liveliness, enthusiasm, and love that he expressed for everything in his life-from saxophone playing to song composing to helicopter piloting and to his medical and scientific studying that revolutionized ophthalmology.
LALES cites higher risk of eye disease for Latinos
October 1st 2004Los Angeles-The results from the Los Angeles Latino Eye Study (LALES) demonstrate Latinos suffer high rates of visual impairment and blindnessin association with high prevalencesof several vision-threatening eye diseases that may often go undiagnosed and untreated, said the study's principal investigator Rohit Varma, MD, MPH
Interim results find phakic IOL useful for high hyperopia
October 1st 2004San Diego-The Artisan Hyperopia IOL (Ophtec BV) appears to be safe, effective, and stable for the treatment of high and extreme hyperopia, according to Edward E. Manche, MD, who reported the interim results of the FDA phase III clinical trial at the American Society of Cataract and Refractive Surgery annual meeting.
Custom treatment improves overcorrection, night vision
October 1st 2004An off-label use of the CustomCornea procedure (Alcon Laboratories) to re-treat symptomatic eyes of patients who had undergone a previous refractive procedure produces dramatic reductions in visual symptoms, according to James J. Salz, MD.
Negative spherical aberration after CK is desirable
October 1st 2004San Diego-Inducing negative spherical aberration may be desirable after conductive keratoplasty (CK). Results of a study showed that patients with negative spherical aberration after CK met the target refractive error and target vision compared with patients with positive spherical aberration, according to Stephen Pascucci, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.
Alcon symposium draws 300 to hear ReSTOR, AquaLase experiences
September 19th 2004Emerging lens extraction and implantation technologies have worldwide appeal among ophthalmologists, and at the European Society of Cataract and Refractive Surgeons meeting, it was evident at an evening symposium conducted by Alcon Laboratories.
New surface ablation approach shows advantages over PRK
September 19th 2004Advanced surface ablation using the MEL 80 laser (ASA80, Carl Zeiss Meditec) showed significant advantages compared with conventional PRK, especially for the recovery of best-corrected visual acuity (BCVA), pain, and haze formation.
Botulinum toxin offers favorable results for diplopia after cataract, refractive surgery
September 19th 2004Investigators at the University of Florence, Florence, Italy, used injections of botulinum toxin into the appropriate muscles of patients who developed diplopia after cataract extraction or refractive surgery and retrospectively evaluated the results.
Inserts using femtosecond laser less traumatic, more accurate than conventional method
September 19th 2004The IntraLase femtosecond laser (IntraLase) allows less traumatic implantation of micro-thin prescription inserts (Intacs, Addition Technology) compared with the conventional mechanical method of implantation.